Okayama M, Oguri K, Yoshida K, Ohkita T
Clinical Research Institute, National Nagoya Hospital, Japan.
J Biol Chem. 1991 Feb 25;266(6):3808-19.
Murine erythroleukemia cells (Friend erythroleukemia cells of a C-10-6 line) synthesized sulfated glycosaminoglycans consisting mainly of heparan sulfate (more than 95%) with a small amount of chondroitin 4-sulfate. The heparan sulfate occurred as proteoglycans, of which the cell-associated component was separated into urea-insoluble (UI) and urea-soluble (US) fractions. The UI proteoglycan consisted of a single homogeneous molecular species with an estimated Mr of 360,000 (C(UI)PG), whereas the US component was composed of two subfractions: a homogeneous species with an Mr of 280,000 (C(US)PGI) and a mixture of compounds with Mr values of less than 80,000 (C(US)PGII), which were isolated in yields of about 110, 340, and 80 micrograms of hexuronate (HexUA), respectively, from 1.37 g of an acetone powder prepared from 5.7 x 10(9) cells in the logarithmic phase of growth. The proteoglycan released into the medium (12 liters) was a single homogeneous species with an Mr of 320,000 (MPG) which was purified in a yield of 500 micrograms of hexuronate. The major, cell-associated proteoglycan, C(US)PGI, had very high contents of serine and glycine, accounting for approximately 80% of the total amino acids. This proteoglycan as well as the other two large proteoglycans, C(UI)PG and MPG, were highly resistant to degradation by various proteinases. These three proteoglycans, C(UI)PG, C(US)PGI, and MPG, had heparan sulfates with estimated Mr values of 32,000, 27,000, and 30,000. On the other hand, the Mr of the smaller proteoglycan, C(UI)PGII, was not significantly different before and after beta-elimination, indicating that it contains only a small peptide, if any. The heparan sulfate of this proteoglycan consisted of smaller and heterogeneous molecular species with Mr values of 26,000, 20,000, and 4,000. Digestion of these heparan sulfates with heparitinase I plus II resulted in almost complete depolymerization and gave six unsaturated disaccharides, delta HexUA-GlcNAc, delta HexUA-Glc-NAc(6-SO4), delta HexUA-GlcNSO3, delta HexUA-GlcNSO3 (6-SO4), delta HexUA(2-SO4)-GlcNSO3, and delta HexUA(2-SO4)-GlcNSO3(6-SO4). The relative amounts of these disaccharides generated from the individual heparan sulfates showed that an average ratio of sulfate residues to repeating disaccharide units of the C(US)PGII-derived heparan sulfate (0.97) was significantly higher than those of the other three large proteoglycan-derived glycosaminoglycans (0.54-0.70).
小鼠红白血病细胞(C - 10 - 6系的弗瑞德红白血病细胞)合成的硫酸化糖胺聚糖主要由硫酸乙酰肝素(超过95%)和少量的硫酸软骨素4 - 硫酸酯组成。硫酸乙酰肝素以蛋白聚糖的形式存在,其中细胞相关成分被分离为不溶于尿素的(UI)和可溶于尿素的(US)部分。UI蛋白聚糖由单一的均质分子种类组成,估计分子量为360,000(C(UI)PG),而US成分由两个亚部分组成:一个分子量为280,000的均质种类(C(US)PGI)和分子量小于80,000的化合物混合物(C(US)PGII),分别从5.7×10⁹处于对数生长期的细胞制备的1.37 g丙酮粉中以约110、340和80微克己糖醛酸(HexUA)的产量分离得到。释放到培养基(12升)中的蛋白聚糖是一种分子量为320,000的单一均质种类(MPG),以500微克己糖醛酸的产量纯化得到。主要的细胞相关蛋白聚糖C(US)PGI具有非常高的丝氨酸和甘氨酸含量,约占总氨基酸的80%。这种蛋白聚糖以及其他两种大的蛋白聚糖C(UI)PG和MPG对各种蛋白酶的降解具有高度抗性。这三种蛋白聚糖C(UI)PG、C(US)PGI和MPG的硫酸乙酰肝素估计分子量分别为32,000、27,000和30,000。另一方面,较小的蛋白聚糖C(UI)PGII在β-消除前后分子量没有显著差异,表明它即使含有肽也只含少量。这种蛋白聚糖的硫酸乙酰肝素由分子量为26,000、20,000和4,000的较小且不均一的分子种类组成。用硫酸乙酰肝素酶I加II消化这些硫酸乙酰肝素导致几乎完全解聚,并产生六种不饱和二糖,即δHexUA - GlcNAc、δHexUA - Glc - NAc(6 - SO4)、δHexUA - GlcNSO3、δHexUA - GlcNSO3(6 - SO4)、δHexUA(2 - SO4) - GlcNSO3和δHexUA(2 - SO4) - GlcNSO3(6 - SO4)。从各个硫酸乙酰肝素产生的这些二糖的相对量表明,C(US)PGII衍生的硫酸乙酰肝素的硫酸酯残基与重复二糖单位的平均比率(0.97)显著高于其他三种大的蛋白聚糖衍生的糖胺聚糖的比率(0.54 - 0.70)。